|
|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |review |
 |
Magee et al (1993) described the
advantages and disadvantages of each of the screening strategies. While
universal screening was supposed to provide a solution to undiagnosed GDM, it
showed that only about half of eligible women would agree to screening, only
27.7% of those with an abnormal GCT had an abnormal OGTT, and those who refused
to screening had in fact more risk factors.
In contrast, high risk group screening would miss about 40% of GDM women. |